Related Experiment Video
Updated: Jul 7, 2026

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
Published on: June 30, 2014
Melioidosis
1Faculty of Tropical Medicine, Mahidol University, 10400, Bangkok, Thailand. fnnjw@diamond.mahidol.ac.th <fnnjw@diamond.mahidol.ac.th>
Abstract:
Melioidosis, which is infection with the gram-negative bacterium Burkholderia pseudomallei, is an important cause of sepsis in east Asia and northern Australia. In northeastern Thailand, melioidosis accounts for 20% of all community-acquired septicaemias, and causes death in 40% of treated patients. B pseudomallei is an environmental saprophyte found in wet soils. It mostly infects adults with an underlying predisposing condition, mainly diabetes mellitus. Melioidosis is characterised by formation of abscesses, especially in the lungs, liver, spleen, skeletal muscle, and prostate. In a third of paediatric cases in southeast Asia, the disease presents as parotid abscess. In northern Australia, 4% of patients present with brain stem encephalitis. Ceftazidime is the treatment of choice for severe melioidosis, but response to high dose parenteral treatment is slow (median time to abatement of fever 9 days). Maintenance antibiotic treatment is with a four-drug regimen of chloramphenicol, doxycycline, and trimethoprim-sulfamethoxazole, or with amoxicillin-clavulanate in children and pregnant women. However, even with 20 weeks' antibiotic treatment, 10% of patients relapse. With improvements in health care and diagnostic microbiology in endemic areas of Asia, and increased travel, melioidosis will probably be recognised increasingly during the next decade.
Insights
Melioidosis, a serious bacterial infection, causes significant sepsis and mortality in Asia and Australia. Early recognition and effective treatment are crucial for improving patient outcomes and reducing relapse rates.
Area of Science:
- Infectious Diseases
- Microbiology
- Public Health
Background:
- Melioidosis, caused by Burkholderia pseudomallei, is a major cause of sepsis in East Asia and Northern Australia.
- The bacterium is an environmental saprophyte found in wet soils, primarily infecting adults with predisposing conditions like diabetes.
- Disease presentation varies, including abscess formation in multiple organs and, in some cases, brain stem encephalitis.
Purpose of the Study:
- To summarize the epidemiology, clinical manifestations, and treatment of melioidosis.
- To highlight the challenges in managing this serious infection, including slow treatment response and high relapse rates.
Main Methods:
- Review of existing literature on melioidosis.
- Analysis of epidemiological data from endemic regions.
- Summary of current treatment guidelines and outcomes.
Main Results:
- Melioidosis accounts for 20% of community-acquired septicaemias in northeastern Thailand, with a 40% mortality rate in treated patients.
- Ceftazidime is the primary treatment for severe cases, but fever abatement is slow (median 9 days).
- Relapse occurs in 10% of patients despite prolonged antibiotic therapy.
Conclusions:
- Melioidosis remains a significant public health concern in endemic areas.
- Improved diagnostics and healthcare, coupled with increased travel, will likely lead to more frequent recognition of melioidosis globally.
- Further research into optimizing treatment strategies and reducing relapse rates is warranted.
Related Concept Videos
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Mitral Regurgitation I: Introduction
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Stenosis I: Introduction
Rocky Mountain Spotted Fever
Multiple Sclerosis l: Introduction

